Tumor‐infiltrating gamma delta T‐cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer
International Journal of Cancer · 2023-11 · 153 (9) · 1684-1697
DOI: 10.1002/ijc.34669 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 02.08.2023. Verfasst von Linyan Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Intraepithelial Lymphocytes, Colorectal Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
The γδT‐cells recognize infected or transformed cells. However, unlike αβT‐cells, γδT‐cells are innate‐like immune cells, with no major histocompatibility complex restriction requirements. γδT‐cells are the main population of intestinal intraepithelial lymphocytes (IELs) and are associated with the antitumor immune response, particularly in colorectal cancer (CRC). Although CD8 + T‐cells exhibit dysfunction and even exhaustion in the tumor microenvironment (TME), which contributes to tumor immune escape, whether the same applies to tumor‐infiltrating (TI)‐γδT‐cells is not completely understood. Here, we sought to investigate the expression pattern of inhibitory receptors and functional state of TI‐γδT‐cells, and reveal the features of exhausted TI‐γδT‐cells in the CRC TME. We demonstrated that TI‐γδT‐cells exhibited exhaustion phenotypes and displayed more severe functional exhaustion than TI‐CD8 + T‐cells or NK‐cells in the TME of CRC. In addition, scRNA‐seq analysis of TI‐γδT‐cells revealed three exhausted subsets with remarkable heterogeneity. The presence of three heterogeneous exhausted γδT‐cell (Tex) populations, including Tex prog , Tex tran and Tex term were further confirmed by flow cytometry, on the basis of PD‐1 and TIM‐3 expression. Finally, we revealed that c‐Maf not only contributed to γδT‐cell exhaustion via upregulation of inhibitory receptors, but also involved in the exhaustion of CD8 + T and NK‐cells. c‐Maf may also be an important contributor to γδT‐cell exhaustion in CRC patients. These findings indicated that TI‐γδT‐cells exhibit phenotypic and functional exhaustion in the CRC TME. The revealed features of exhausted TI‐γδT‐cells may provide help for understanding the mechanisms and the association of γδT‐cell exhaustion with tumor development and pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Institute of Diagnostics, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Cai Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yu, L., Wang, Z., Hu, Y., Wang, Y., Lu, N., & Zhang, C. (2023). Tumor‐infiltrating gamma delta T‐cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer. International Journal of Cancer, 153(9), 1684-1697. https://doi.org/10.1002/ijc.34669
Vancouver
Yu L, Wang Z, Hu Y, Wang Y, Lu N, Zhang C. Tumor‐infiltrating gamma delta T‐cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer. International Journal of Cancer. 2023;153(9):1684-1697. doi:10.1002/ijc.34669
BibTeX
@article{Yu2023,
author = {Yu, Linyan and Wang, Zhaozhong and Hu, Yuan and Wang, Yanan and Lu, Nan and Zhang, Cai},
title = {Tumor‐infiltrating gamma delta T‐cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer},
journal = {International Journal of Cancer},
year = {2023},
volume = {153},
number = {9},
pages = {1684--1697},
doi = {10.1002/ijc.34669}
}
EUVIMED